TTLL12: A promising therapeutic target for prostate cancer

被引：0
作者：
Wasylyk, Bohdan [1 ]
Semenchenko, Kostyantin [1 ]
Wasylyk, Christine [1 ]
Brants, Jan [1 ]
Jung, Alain [2 ]
Abecassis, Joseph [2 ]
机构：
[1] IGBMC, Illkirch Graffenstaden, France
[2] Canc Paul Strauss, Strasbourg, France
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4015
引用
收藏
页数：2
相关论文
共 50 条
[1]   TTLL12 expression in ovarian cancer correlates with a poor outcome [J].
Yang, Shangjie ;
Liang, Yanping ;
Qian, Haihong ;
Li, Qiuhong .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (02) :239-247
[2]   Effect of TTLL12 on tubulin tyrosine nitration as a novel target for screening anticancer drugs in vitro [J].
Xue, Lingli ;
Zeng, Yan ;
Fang, Chuan ;
Cheng, Wei ;
Li, Yadong .
ONCOLOGY LETTERS, 2020, 20 (06)
[3]   Identification of a novel transcript isoform of the TTLL12 gene in human cancers [J].
Wen, Ruiling ;
Xiao, Yingying ;
Zhang, Yuhua ;
Yang, Min ;
Lin, Yongping ;
Tang, Jun .
ONCOLOGY REPORTS, 2016, 36 (06) :3172-3180
[4]   TTLL12 is required for primary ciliary axoneme formation in polarized epithelial cells [J].
Ceglowski, Julia ;
Hoffman, Huxley K. ;
Neumann, Andrew J. ;
Hoff, Katie J. ;
McCurdy, Bailey L. ;
Moore, Jeffrey K. ;
Prekeris, Rytis .
EMBO REPORTS, 2024, 25 (01) :198-227
[5]   HMGB1: A Promising Therapeutic Target for Prostate Cancer [J].
Gnanasekar, Munirathinam ;
Kalyanasundaram, Ramaswamy ;
Zheng, Guoxing ;
Chen, Aoshuang ;
Bosland, Maarten C. ;
Kajdacsy-Balla, Andre .
PROSTATE CANCER, 2013, 2013
[6]   NF-κB signaling in prostate cancer: A promising therapeutic target? [J].
Garima Jain ;
Marcus V. Cronauer ;
Mark Schrader ;
Peter Möller ;
Ralf B. Marienfeld .
World Journal of Urology, 2012, 30 :303-310
[7]   NF-κB signaling in prostate cancer: A promising therapeutic target? [J].
Jain, Garima ;
Cronauer, Marcus V. ;
Schrader, Mark ;
Moeller, Peter ;
Marienfeld, Ralf B. .
WORLD JOURNAL OF UROLOGY, 2012, 30 (03) :303-310
[8]   MUC1 is a promising therapeutic target for prostate cancer therapy [J].
Li, Y. ;
Cozzi, P. J. .
CURRENT CANCER DRUG TARGETS, 2007, 7 (03) :259-271
[9]   TTLL12 Inhibits the Activation of Cellular Antiviral Signaling through Interaction with VISA/MAVS [J].
Ju, Lin-Gao ;
Zhu, Yuan ;
Lei, Pin-Ji ;
Yan, Dong ;
Zhu, Kun ;
Wang, Xiang ;
Li, Qing-Lan ;
Li, Xue-Jing ;
Chen, Jian-Wen ;
Li, Lian-Yun ;
Wu, Min .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :1274-1284
[10]   TUMOR-DERIVED TTLL12 RECRUITS MYELOID-DERIVED SUPPRESSOR CELLS TO PROMOTE TUMOR PROGRESSION OF COLORECTAL CANCER [J].
Chen, Dongwen ;
Cai, Kuntai ;
Hu, Peishan ;
Wu, Xiao-Jian .
GASTROENTEROLOGY, 2024, 166 (05) :S1280-S1281
12345